Focal Healthcare will be exhibiting at the 34th Annual EAU Congress in Barcelona on March 16-18, 2019 at the Fira Gran Via. Visit us at stand C44, Hall 8 to get a demonstration of our Fusion Bx 2.0 prostate fusion biopsy system.
The EU is now seeing a fundamental shift in prostate cancer diagnosis after the release of the PRECISION study results at the Annual EAU Congress last year. The use of multi-parametric MRI and MRI-targeted biopsies are becoming essential tools for providing early and accurate detection of prostate cancer.
Our Fusion Bx uses targets identified in MRI to allow urologists to visualize lesions on live ultrasound images and a 3D model during a biopsy. The Fusion Bx features a semi-robotic arm and intuitive interface that strikes the optimal balance between accuracy and ease-of-use. Moreover, a hands-free counterbalance that keeps the ultrasound probe steady, along with patient motion compensation allow procedures to advance in short time and with minimal resources. There’s no better time to integrate prostate fusion into your clinical workflow.